Literature DB >> 12029632

Treatment of hepatocellular carcinoma with radiofrequency ablation: radiologic-histologic correlation during follow-up periods.

Manabu Morimoto1, Kazuya Sugimori, Kazuhito Shirato, Atsushi Kokawa, Naohiko Tomita, Takafumi Saito, Noriko Tanaka, Akinori Nozawa, Masamichi Hara, Hisahiko Sekihara, Hiroshi Shimada, Toshio Imada, Katsuaki Tanaka.   

Abstract

To determine whether radiographic images after radiofrequency (RF)-induced coagulation necrosis are correlated with the pathologic effects, we evaluated the morphology and histologic characteristics of RF ablation lesions over a 6-month follow-up period and compared the results with those of radiologic studies. Thirty-three hepatocellular carcinoma (HCC) tumors with a maximum diameter of 3 cm or less were treated percutaneously by using RF ablation in 26 patients. Six treated tumors were resected 4 weeks after ablation; the remaining 27 treated tumors underwent a biopsy procedure by using an 18-gauge fine needle 3 days, 4 weeks, and 24 weeks after ablation. The excised or biopsied lesions were examined by using histologic methods; the findings were then compared with those of contrast-enhanced computed tomography (CT). Three days after ablation, a core of hypoattenuation surrounded by an enhanced/hemorrhagic rim was observed on the contrast-enhanced CT images. Hematoxylin-eosin-stained specimens were inconclusive as to whether or not cellular viability remained; however, cell viability as determined by the presence of histochemical (lactate-dehydrogenase, maleate-dehydrogenase, and the reduced form of nicotinamide-adenine dinucleotide phosphate [NADPH]-diaphorase) stains was absent, suggesting 100% cellular destruction in the ablated lesion. Four and 24 weeks after ablation, the sizes of the ablated lesions were progressively smaller on the CT images; the histochemical stains remained superior to the hematoxylin-eosin stains for obtaining a definite diagnosis of cell death. We conclude that irreversible cellular destruction, as determined by the absence of positive histochemical staining patterns, was useful for evaluating the pathologic thermal effect of RF ablation. These pathologic findings can be correlated with those of contrast-enhanced CT.

Entities:  

Mesh:

Year:  2002        PMID: 12029632     DOI: 10.1053/jhep.2002.33635

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  43 in total

1.  Bipolar radiofrequency ablation in ex vivo bovine liver with the open-perfused system versus the cooled-wet system.

Authors:  Jeong Min Lee; Joon Koo Han; Se Hyung Kim; Kyu Li Sohn; Seung Hong Choi; Byung Ihn Choi
Journal:  Eur Radiol       Date:  2004-07-10       Impact factor: 5.315

2.  [Radiofrequency ablation as a palliative therapy option in ENT tumors: in vivo and in vitro testing].

Authors:  S Bucher; J Hornung; V Bonkowsky; H Iro; J Zenk
Journal:  HNO       Date:  2010-04       Impact factor: 1.284

Review 3.  Local recurrence after hepatic radiofrequency coagulation: multivariate meta-analysis and review of contributing factors.

Authors:  Stefaan Mulier; Yicheng Ni; Jacques Jamart; Theo Ruers; Guy Marchal; Luc Michel
Journal:  Ann Surg       Date:  2005-08       Impact factor: 12.969

4.  Real time monitoring of radiofrequency ablation based on MR thermometry and thermal dose in the pig liver in vivo.

Authors:  Olivier Seror; Matthieu Lepetit-Coiffé; Brigitte Le Bail; Baudouin Denis de Senneville; Hervé Trillaud; Chrit Moonen; Bruno Quesson
Journal:  Eur Radiol       Date:  2007-09-26       Impact factor: 5.315

5.  18F-FDG PET/CT Is an Immediate Imaging Biomarker of Treatment Success After Liver Metastasis Ablation.

Authors:  Francois Cornelis; Vlasios Sotirchos; Elena Violari; Constantinos T Sofocleous; Heiko Schoder; Jeremy C Durack; Robert H Siegelbaum; Majid Maybody; John Humm; Stephen B Solomon
Journal:  J Nucl Med       Date:  2016-02-23       Impact factor: 10.057

6.  Re: Assessment of viable tumour tissue attached to needle applicators after local ablation of liver tumours.

Authors:  C T Sofocleous; N Petre; K Manova-Todorova; L Petrovic; M Gonen
Journal:  Dig Surg       Date:  2009-11-13       Impact factor: 2.588

Review 7.  Image guided tumour ablation.

Authors:  A R Gillams
Journal:  Cancer Imaging       Date:  2005-09-21       Impact factor: 3.909

Review 8.  Combining locoregional therapies in the treatment of hepatocellular carcinoma.

Authors:  Mikhail C S S Higgins; Michael C Soulen
Journal:  Semin Intervent Radiol       Date:  2013-03       Impact factor: 1.513

9.  [Present state of radio frequency ablation of liver tumors in Germany].

Authors:  M Birth; P Hildebrand; G Dahmen; A Ziegler; D C Bröring; C Hillert; H P Bruch
Journal:  Chirurg       Date:  2004-04       Impact factor: 0.955

10.  Comparison of wet radiofrequency ablation with dry radiofrequency ablation and radiofrequency ablation using hypertonic saline preinjection: ex vivo bovine liver.

Authors:  Jeong Min Lee; Joon Koo Han; Se Hyung Kim; Kyung Sook Shin; Jae Young Lee; Hee Sun Park; Hurn Hur; Byung Ihn Choi
Journal:  Korean J Radiol       Date:  2004 Oct-Dec       Impact factor: 3.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.